Castle Announces Early Exploratory Study Data for Potential Development of a Complementary Test to Accompany DecisionDx®-UM That Could Aid in the Early Detection of Uveal Melanomas

Renowned eye cancer expert and study investigator, Amy Schefler, M.D., will share early data from a study to explore the potential for developing a complementary test that would be tailored for...

Related Keywords

United States ,Texas ,American ,Decisiondx Diffdx ,Castle Biosciences ,Robert Cook ,Castle Bioscience ,Amy Schefler ,Instagram ,American Joint Committee On Cancer ,Linkedin ,Ut Southwestern Medical Center ,Castle Biosciences Inc ,Facebook ,National Comprehensive Cancer Network ,Nasdaq ,Medical Center ,Retina Consultants ,Uveal Melanoma Liquid Biopsies ,Are We Going ,Loch Ness Monster ,Ongoing Exploratory Study ,American Joint Committee ,Staging Manual ,Path Melanoma ,Decisiondx Diffdx Melanoma ,Markets ,